PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Smartphone applications assessing melanoma risk appear to be highly variable

2013-01-17
(Press-News.org) CHICAGO – Performance of smartphone applications in assessing melanoma risk is highly variable and 3 of 4 applications incorrectly classified 30 percent or more of melanomas as unconcerning, according to a report published Online First by JAMA Dermatology, a JAMA Network publication.

To measure the performance of smartphone applications that evaluate photographs of skin lesions and provide the user with feedback about the likelihood of malignancy, Joel A. Wolf, B.A., and colleagues at the University of Pittsburgh Medical Center, tested the sensitivity, specificity, and positive and negative predictive values of four smartphone applications.

The authors included 188 images of lesions in the analysis, each of which was evaluated by the four smartphone applications, and the test result was recorded as positive, negative or unevaluable. Of these lesions, 60 were melanoma and the remaining 128 were benign.

Sensitivity of the four applications tested ranged from 6.8 percent to 98.1 percent; specificity ranged from 30.4 percent to 93.7 percent; positive predictive value ranged from 33.3 percent to 42.1 percent; and negative predictive value ranged from 65.4 percent to 97 percent. The highest sensitivity for melanoma diagnosis was observed for an application that sends the image directly to a board-certified dermatologist for analysis, while the lowest sensitivity for melanoma diagnosis were applications that use automated algorithms to analyze images.

The authors suggest that reliance on these applications, which are not subject to regulatory oversight, and not seeking medical consultation can delay the diagnosis of melanoma and potentially harm users.

"Physicians must be aware of these applications because the use of medical applications seems to be increasing over time… the dermatologist should be aware of those relevant to our field to aid us in protecting and educating our patients," the authors conclude. (JAMA Dermatology. Published online January 16, 2013. doi:10.1001/jamadermatol.2013.2382. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: This study was supported by grants from the National Institutes of Health. Dr. Ferris also reported having served as an investigator and consultant for MELA Sciences, Inc. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

### To contact corresponding author Laura K. Ferris, M.D., Ph.D., call Carrie Stevenson at 412-586-9778 or email beckerc@upmc.edu.


ELSE PRESS RELEASES FROM THIS DATE:

UAlberta medical researchers find DNA marker that predicts breast cancer recurrence

2013-01-17
Medical researchers at the University of Alberta tested the DNA of more than 300 women in Alberta and discovered a 'genetic marker' method to help accurately profile which women were more apt to have their breast cancer return years later. Sambasivarao Damaraju, a professor with the Faculty of Medicine & Dentistry, and at the Cross Cancer Institute just published his team's findings in the peer-reviewed journal, PLoS One. Using a simple blood test, Damaraju and his team, which included his PhD student Yadav Sapkota, scanned the entire human genome of 369 women who had ...

New study finds malaria, typhoid -- not Ebola -- biggest health threat for travelers to tropics

2013-01-17
Contact: Bridget DeSimone bdesimone@burnesscommunications.com 301-280-5735 Preeti Singh psingh@burnesscommunications.com 301-280-5722 The American Journal of Tropical Medicine and Hygiene New study finds malaria, typhoid -- not Ebola -- biggest health threat for travelers to tropics DEERFIELD, IL. (January 16, 2013)—Feeling feverish after a visit to the tropics? It may not just be a bout with this year's flu. If you're a Western traveler, malaria and typhoid fever should top the list of diseases to discuss with your doctor when you return, especially following ...

Light exposure during pregnancy key to normal eye development

2013-01-17
Contact: Nick Miller nicholas.miller@cchmc.org 513-803-6035 Cincinnati Children's Hospital Medical Center Contact: Jason Bardi jason.bardi@ucsf.edu 415-502-4608 University of California, San Francisco Light exposure during pregnancy key to normal eye development CINCINNATI – New research in Nature concludes the eye – which depends on light to see – also needs light to develop normally during pregnancy. Scientists say the unexpected finding offers a new basic understanding of fetal eye development and ocular diseases caused by vascular disorders – ...

Scientists identify new 'social' chromosome in the red fire ant

2013-01-17
The red fire ants live in two different types of colonies: some colonies strictly have a single queen while other colonies contain hundreds of queens. Publishing in the journal Nature (Wednesday 16 January 2013), scientists have discovered that this difference in social organisation is determined by a chromosome that carries one of two variants of a 'supergene' containing more than 600 genes. The two variants, B and b, differ in structure but have evolved similarly to the X and Y chromosomes that determine the sex of humans. If the worker fire ants in a colony carry ...

An early sign of spring, earlier than ever

2013-01-17
Record warm temperatures in 2010 and 2012 resulted in the earliest spring flowering in the eastern United States in more than 150 years, researchers at Harvard University, Boston University and the University of Wisconsin have found. "We're seeing plants that are now flowering on average over three weeks earlier than when they were first observed – and some species are flowering as much as six weeks earlier," said Charles Davis, a Harvard Professor of Organismic and Evolutionary Biology and the study's senior author. "Spring is arriving much earlier today than it has ...

Inaccurate diagnoses of melanoma by smartphone apps could delay doctor visits, life-saving treatment

2013-01-17
PITTSBURGH, Jan. 16, 2013 – Smartphone applications that claim to evaluate a user's photographs of skin lesions for the likelihood of cancer instead returned highly variable and often inaccurate feedback, according to a study led by researchers at the University of Pittsburgh School of Medicine. The findings, published in JAMA Dermatology and available online today, suggest that relying on these "apps" instead of consulting with a physician may delay the diagnosis of melanoma and timely, life-saving treatment. "Smartphone usage is rapidly increasing, and the applications ...

H1N1 flu shots are safe for pregnant women

2013-01-17
Norwegian pregnant women who received a vaccine against the 2009 H1N1 influenza virus showed no increased risk of pregnancy loss, while pregnant women who experienced influenza during pregnancy had an increased risk of miscarriages and still births, a study has found. The study suggests that influenza infection may increase the risk of fetal loss. Scientists at the U.S. National Institutes of Health and the Norwegian Institute of Public Health (NIPH) published their findings online Jan. 17 in the New England Journal of Medicine. The research was conducted following the ...

Study: Antiretroviral therapy for HIV-1 in first 4 months is crucial

2013-01-17
SAN ANTONIO, Texas, U.S.A. (Jan. 16, 2013) — Patients who are started on antiretroviral therapy for HIV-1 infection within four months of estimated infection date — and who have higher counts of CD4+ T-cells at the initiation of therapy — demonstrate a stronger recovery of CD4+ T-cell counts than patients in whom therapy is started later, a new study shows. The report, to be published Thursday in The New England Journal of Medicine, is co-authored by physicians of UT Medicine San Antonio and the University of California, San Diego and drew data from 468 patients followed ...

Early treatment for HIV slows damage to immune system and reduces risk of transmission

2013-01-17
A 48-week course of antiretroviral medication taken in the early stages of HIV infection slows the damage to the immune system and delays the need for long term treatment, according to research published today in the New England Journal of Medicine (1). However, the delay was only marginally longer than the time already spent on treatment. The study, the largest clinical trial ever undertaken looking at treating people with recent HIV infection, also suggests that the treatment lowers the amount of virus in the blood for up to sixty weeks after it is stopped, which potentially ...

Checklists in operating rooms improve performance during crises

2013-01-17
Boston – In an airplane crisis—an engine failure, a fire—pilots pull out a checklist to help with their decision-making. But in an operating room crisis—massive bleeding, a patient's heart stops—surgical teams don't. Given the complexity of judgment and circumstances, standard practice is for teams to use memory alone. In a new study published in the January 17 issue of the New England Journal of Medicine, however, researchers at Ariadne Labs, a joint center for health system innovation at Brigham and Women's Hospital and Harvard School of Public Health, have found that ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Smartphone applications assessing melanoma risk appear to be highly variable